• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视力障碍及行动不便与死亡率的关系。

Relationship of Visual Impairment and Poor Mobility With Mortality.

作者信息

Thompson Atalie C, Rigdon Joseph, Miller Michael E, Kritchevsky Stephen B

机构信息

Department of Surgical Ophthalmology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.

Division of Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.

出版信息

J Am Geriatr Soc. 2025 Jun 18. doi: 10.1111/jgs.19584.

DOI:10.1111/jgs.19584
PMID:40530606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12354233/
Abstract

BACKGROUND

Older adults with visual impairment (VI) have a greater risk of mortality, but the reasons are poorly understood. We have shown that older adults with VI are more likely to have poor mobility performance on the short physical performance battery (SPPB). In this analysis, we examined whether VI predicted mortality over 10 years and if this was related to poor baseline mobility (SPPB < 9).

METHODS

We analyzed 2457 older adults (mean age 75.6 (±2.8) years, 38.5% black, 51.9% female) who completed vision testing at the year 3 visit in the Health, Aging and Body Composition study. Cox proportional hazards models for mortality were right-censored at 10 years and adjusted for demographic and clinical comorbidities. VI (visual acuity < 20/40 or log contrast sensitivity < 1.55 or stereoacuity > 85) and SPPB < 9 were tested as main predictors and their interaction was tested.

RESULTS

In separate multivariable models, VI (HR 1.511, 95% CI [1.335-1.709], p < 0.0001) and SPPB < 9 (HR 1.442, 95% CI [1.210-1.717], p < 0.0001) each predicted mortality. When including both poor mobility and vision variables as main effects, both poor mobility and impaired vision remained significant predictors of mortality in all models (all p < 0.001). When adding poor mobility (as a main effect and interaction with VI) and using unimpaired vision and mobility as the reference, those with only VI (HR 1.467, 95% CI [1.287-1.672], p < 0.0001) or only poor mobility (HR 1.380, 95% CI [0.963-1.979], p = 0.0792) had similar HRs, while those with both VI and poor mobility had an increased mortality risk (HR 2.035, 95% CI [1.643-2.522], p < 0.0001), but the interaction was not significant (p = 0.981).

CONCLUSIONS

Older adults with both VI and poor mobility are at an additive increased risk of mortality. Future interventions may want to target older adults with both VI and poor mobility to improve survival.

摘要

背景

视力障碍(VI)的老年人死亡风险更高,但原因尚不清楚。我们已经表明,患有视力障碍的老年人在简短身体功能测试(SPPB)中更有可能身体活动能力较差。在本分析中,我们研究了视力障碍是否能预测10年以上的死亡率,以及这是否与基线身体活动能力差(SPPB<9)有关。

方法

我们分析了2457名老年人(平均年龄75.6(±2.8)岁,38.5%为黑人,51.9%为女性),他们在健康、衰老和身体成分研究的第3年随访时完成了视力测试。死亡率的Cox比例风险模型在10年时进行右删失,并对人口统计学和临床合并症进行了调整。将视力障碍(视力<20/40或对数对比敏感度<1.55或立体视锐度>85)和SPPB<9作为主要预测因素进行测试,并测试它们的相互作用。

结果

在单独的多变量模型中,视力障碍(风险比[HR]1.511,95%置信区间[CI][1.335-1.709],p<0.0001)和SPPB<9(HR 1.442,95%CI[1.210-1.717],p<0.0001)均能预测死亡率。当将身体活动能力差和视力变量都作为主要效应纳入时,身体活动能力差和视力受损在所有模型中仍然是死亡率的显著预测因素(所有p<0.001)。当加入身体活动能力差(作为主要效应以及与视力障碍的相互作用)并以视力和身体活动能力正常作为参照时,仅患有视力障碍者(HR 1.467,95%CI[1.287-1.672],p<0.0001)或仅身体活动能力差者(HR 1.380,95%CI[0.963-1.979],p=0.0792)的风险比相似,而同时患有视力障碍和身体活动能力差者的死亡风险增加(HR 2.035,95%CI[1.643-2.522],p<0.0001),但相互作用不显著(p=0.981)。

结论

同时患有视力障碍和身体活动能力差的老年人死亡风险额外增加。未来的干预措施可能需要针对同时患有视力障碍和身体活动能力差的老年人,以提高生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b4/12554849/3870ae5ca046/JGS-73-3184-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b4/12554849/3870ae5ca046/JGS-73-3184-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b4/12554849/3870ae5ca046/JGS-73-3184-g001.jpg

相似文献

1
Relationship of Visual Impairment and Poor Mobility With Mortality.视力障碍及行动不便与死亡率的关系。
J Am Geriatr Soc. 2025 Jun 18. doi: 10.1111/jgs.19584.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Community screening for visual impairment in older people.老年人视力障碍的社区筛查。
Cochrane Database Syst Rev. 2018 Feb 20;2(2):CD001054. doi: 10.1002/14651858.CD001054.pub3.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
6
Surgical interventions for treating extracapsular hip fractures in older adults: a network meta-analysis.老年人髋关节囊外骨折的手术干预:一项网络荟萃分析。
Cochrane Database Syst Rev. 2022 Feb 10;2(2):CD013405. doi: 10.1002/14651858.CD013405.pub2.
7
Exercise for acutely hospitalised older medical patients.急性住院老年医学患者的运动治疗。
Cochrane Database Syst Rev. 2022 Nov 10;11(11):CD005955. doi: 10.1002/14651858.CD005955.pub3.
8
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.

本文引用的文献

1
The Association of Short Physical Performance Battery With Mortality and Hospitalization in Patients Receiving Hemodialysis.短体适能电池评估与血液透析患者死亡率和住院率的相关性。
J Ren Nutr. 2024 May;34(3):235-242. doi: 10.1053/j.jrn.2023.10.010. Epub 2023 Nov 3.
2
Vision Rehabilitation Preferred Practice Pattern®.视力康复首选实践模式®
Ophthalmology. 2023 Mar;130(3):P271-P335. doi: 10.1016/j.ophtha.2022.10.033. Epub 2022 Dec 19.
3
Relationship of Self-reported and Performance-based Visual Function With Performance-based Measures of Physical Function: The Health ABC Study.
自我报告的和基于表现的视觉功能与基于表现的身体功能测量的关系:健康 ABC 研究。
J Gerontol A Biol Sci Med Sci. 2023 Oct 28;78(11):2060-2069. doi: 10.1093/gerona/glac225.
4
Predicting falls in older adults: an umbrella review of instruments assessing gait, balance, and functional mobility.预测老年人跌倒:评估步态、平衡和功能移动性的仪器的伞式综述。
BMC Geriatr. 2022 Jul 25;22(1):615. doi: 10.1186/s12877-022-03271-5.
5
Visual risk factors for falls in older adults: a case-control study.老年人跌倒的视觉风险因素:病例对照研究。
BMC Geriatr. 2022 Feb 17;22(1):134. doi: 10.1186/s12877-022-02784-3.
6
Visual Impairment and Objectively Measured Physical Activity in Middle-Aged and Older Adults.中老年人群的视力障碍与客观测量的身体活动
J Gerontol A Biol Sci Med Sci. 2021 Nov 15;76(12):2194-2203. doi: 10.1093/gerona/glab103.
7
Association between vision impairment and mortality: a systematic review and meta-analysis.视力障碍与死亡率的关联:系统评价和荟萃分析。
Lancet Glob Health. 2021 Apr;9(4):e418-e430. doi: 10.1016/S2214-109X(20)30549-0. Epub 2021 Feb 16.
8
Vision Impairment and Cognitive Outcomes in Older Adults: The Health ABC Study.老年人的视力障碍和认知结果:健康 ABC 研究。
J Gerontol A Biol Sci Med Sci. 2019 Aug 16;74(9):1454-1460. doi: 10.1093/gerona/gly244.
9
Presence of Vision Impairment and Risk of Hospitalization among Elderly Medicare Beneficiaries.老年医疗保险受益人中视力障碍的存在与住院风险
Ophthalmic Epidemiol. 2017 Dec;24(6):364-370. doi: 10.1080/09286586.2017.1296961. Epub 2017 Mar 27.
10
Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis.简短身体机能测试组合与全因死亡率:系统评价与荟萃分析
BMC Med. 2016 Dec 22;14(1):215. doi: 10.1186/s12916-016-0763-7.